Officers and directors
Severin Schwan
Chairman of the Corporate Executive Committee, Chief Executive Officer
Alan Hippe
Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Stephan Feldhaus
Member of the Enlarged Corporate Executive Committee, Head Group Communications
Sophie Kornowski-Bonnet
Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering
Osamu Nagayama
Member of the Enlarged Corporate Executive Committee, President and Chief Executive Officer of Chugai
John C Reed MD,PhD
Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Richard H. Scheller Ph.D.
Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Urs Jaisli
Chief Compliance Officer
Gottlieb A. Keller
Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Silvia Ayyoubi
Member of the Corporate Executive Committee, Head of Group Human Resources
Address
Grenzacherstrasse 124
Basel, 4070
Switzerland
+41-9-732354295 (Phone)
Basel, 4070
Switzerland
+41-9-732354295 (Phone)
Website links
External links
Discussion Group - Google Finance
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions. Diagnostics include five business areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan.
Related companies
| Name | Exchange | Symbol | Last trade | Change | Mkt cap | |
| GENMAB AS DK 1 | ETR | GE9 | 3.96 | * | ||
| PHARMASSET INC DL-,001 | FRA | BW6 | 105.70 | |||
| INHIBITEX INC. DL-,001 | FRA | IHI | 19.58 | |||
| Lobeck Medical AG | ETR | 34L | 0.0000 | * | ||
| PAP Property & Participation Holding AG | ETR | 3ME | 0.0100 | * | ||
| Roche Holding AG | Private | |||||
| TG Therapeutics Inc | Private | |||||
| Siemens Healthcare Diagnostics Inc. | Private | |||||
| Nipro Diagnostics, Inc. | Private | |||||
| FibroGen, Inc. | Private | |||||
| Actelion Pharmaceuticals UK Ltd. | Private |